MCB vs MFIC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
MCB presents a stark dichotomy between extreme valuation attractiveness and deteriorating fundamental health, highlighted by a weak Piotroski F-Score of 2/9. While the stock trades significantly below its Graham Number ($115.79) and Intrinsic Value ($238.66), the low F-Score suggests poor quality of earnings or declining operational efficiency. Explosive YoY earnings growth (101.4%) is offset by bearish insider sentiment and a very weak technical trend (10/100). The company's reliance on Banking-as-a-Service (BaaS) introduces regulatory risks that may be pricing into the current discount.
MFIC exhibits severe fundamental deterioration, highlighted by a weak Piotroski F-Score of 2/9 and a highly unsustainable dividend payout ratio of 223.53%. While the stock trades at a discount to book value (P/B 0.83) and below its Graham Number ($14.73), these value metrics are offset by negative revenue growth and a growth-based intrinsic value of only $4.76. The combination of liquidity pressure (Current Ratio 0.92) and a bearish technical trend suggests significant downside risk. The current dividend yield is a 'value trap' given that payouts far exceed earnings.
Compare Another Pair
Related Comparisons
MCB vs MFIC: Head-to-Head Comparison
This page compares Metropolitan Bank Holding Corp. (MCB) and MidCap Financial Investment Corporation (MFIC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.